Commentary: ursodeoxycholic acid as chemoprevention in inflammatory bowel disease and primary sclerosing cholangitis

Affiliations

¹ Digestive Diseases Service, Hospital Universitario La Princesa, Instituto de Investigación Sanitaria Princesa, Madrid, Spain. csantander.hlpr@salud.madrid.org

Comment

C Santander et al. Aliment Pharmacol Ther. 2012 Apr.

. 2012 Apr;35(7):846; discussion 847.

doi: 10.1111/j.1365-2036.2012.05019.x.

¹ Digestive Diseases Service, Hospital Universitario La Princesa, Instituto de Investigación Sanitaria Princesa, Madrid, Spain. csantander.hlpr@salud.madrid.org

No abstract available

Comment on

High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia.
Lindström L, Boberg KM, Wikman O, Friis-Liby I, Hultcrantz R, Prytz H, Sandberg-Gertzén H, Sangfelt P, Rydning A, Folvik G, Gangsøy-Kristiansen M, Danielsson A, Bergquist A. Lindström L, et al. Aliment Pharmacol Ther. 2012 Feb;35(4):451-7. doi: 10.1111/j.1365-2036.2011.04966.x. Epub 2012 Jan 5. Aliment Pharmacol Ther. 2012. PMID: 22221173 Clinical Trial.